Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin

Blood

Volumn 93, Issue 1, 1999, Pages 157-164

  Harada, Naoaki ^b   Okajima, Kenji ^a   Kushimoto, Shigeki ^b   Isobe, Hirotaka ^b   Tanaka, Keiichi ^b  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETONE; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; DANSYL CHLORIDE; GLYCOSAMINOGLYCAN; ILOPROST; INDOMETACIN; MYELOPEROXIDASE; PROSTACYCLIN; SULFONIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CHEMICAL MODIFICATION; CONTROLLED STUDY; ENDOTHELIUM CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; LIVER BLOOD FLOW; LIVER INJURY; LIVER ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; REPERFUSION INJURY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032939332     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.1.157     Document Type: Article

References (51)

1. Rosenberg RD: Biochemistry of heparin antithrombin interactions, and the physiological role of this natural anticoagulant mechanism. Am J Med 87: 2S, 1989 (suppl 3B)
2. Granger DN, Kubes P: The microcirculation and inflammation: Modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55: 662, 1994
3. Horie S, Ishii H, Kazama M: Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells. Thromb Res 59: 895, 1990
4. Yamauchi T, Umeda F, Inoguchi T, Nawata H: Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Bichem Biophys Res Commun 163: 1404, 1989
5. Eisenhut T, Sinha B, Grottrup-Wolfers E, Semmler J, Siess W, Endres S: Prostacyclin analogs suppress the synthesis of tumor necrosis factor-α in LPS-stimulated human peripheral blood mononuclear cells. Immunopharmacology 26: 259, 1993
6. Armstrong JM, Chapple D, Dusting GJ, Hughes R, Moncada S, Vane JR: Cardiovascular actions of prostacyclin (PGI2) in chloralose anesthetized dogs. Br J Pharmacol 61: 136, 1977
7. Kainoh M, Imai R, Umetsu T, Hattori M, Nishio S: Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes. Biochem Pharmacol 39: 477, 1990
8. Boxer LA, Allen JM, Schmidt M, Yoder M, Baehner RL: Inhibition of polymorphonuclear leukocyte adherence by prostacyclin. J Lab Clin Med 95: 672, 1980
9. Starkey PM: Elastase and cathepsin G: The serine protease of human neutrophil leukocytes and spleen, in Barret AJ (ed): Proteinases in Mammalian Cells and Tissues. Amsterdam, The Netherlands, Elsevier/ North Holland, 1977, p 57
10. Weiss SJ, LoBuglio AF: An oxygen-dependent mechanism of neutrophil-mediated cytotoxicity. Blood 55: 1020, 1980
11. Weiss SJ, Young J, LoBuglio AF, Slivka A, Nimeh NF: Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest 68: 714, 1981
12. Komatsu H, Koo A, Ghadishah E, Zeng H, Kuhlenkamp JF, Inoue M, Guth PH, Kaplowitz N: Neutrophil accumulation in ischemic reperfused rat liver: Evidence for a role for superoxide free radicals. Am J Physiol 262: G669, 1992
13. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ: Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukoc Biol 52: 377, 1992
14. Emerson TE, Fournel MA, Redens TB, Taylor FB: Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia. Am J Med 87: 27S, 1989 (suppl 3B)
15. Triantaphyllopoulos DC: Effect of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin. Thromb Haemost 51: 232, 1984
16. Coalson JJ, Benjamin B, Archer LT, Beller B, Gilliam CL, Taylor FB, Hinshaw LB: Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. Circ Shock 5: 423, 1978
17. Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K: Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am J Physiol 270: L921, 1996
18. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN: Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 253:H699, 1987
19. Atalla SL, Toledo-Pereyra H, MacKenzie GH, Cederna JP: Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 40: 584, 1985
20. Hasselgren PO: Prevention and treatment of ischemia of the liver. Surg Gynecol Obstet 164: 187, 1987
21. Keller GA, West MA, Cerra FB, Simmons RL: Macrophage-mediated modulation of hepatic function in multi-system failure. J Surg Res 39: 555, 1985
22. Jaeschke H, Farhood A, Smith CW: Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 4: 3355, 1990
23. Vollmar B, Glasz J, Menger MD, Messmer K: Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 117: 195, 1995
24. Farhood A, McGuire GM, Manning AM, Miyasaka M, Smith CW, Jaeschke H: Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol 57: 368, 1995
25. Miller-Anderson M, Borg H, Anderson LO: Purification of antithrombin III by affinity chromatography. Thromb Res 5: 439, 1974
26. Hayashi H, Chaudry IH, Clemens MG, Baue AE: Hepatic ischemia models for determining the effects of ATP-MgC12 treatment. J Surg Res 40: 167, 1986
27. Lee SM, Clemens MG: Effect of α-tocopherol on hepatic mixed function oxidases in hepatic ischemia/reperfusion. Hepatology 15:176, 1992
28. Kushimoto S, Okajima K, Uchiba M, Murakami K, Harada N, Okabe H, Takatsulki K: Role of granulocyte elastase in ischemia/ reperfusion injury of rat liver. Crit Care Med 24: 1908, 1996
29. Clauss A: Rapid physiological coagulation method for the determination of fibrinogen. Acta Haematol 17: 237, 1957
30. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K: Activated protein C attenuates endotoxininduced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87: 642, 1996
31. Puchtler H, Waldrop FS, Meloan SN: On the mechanism of Mallory's phosphotungstic acid-haematoxylin stain. J Microsc 119: 383, 1980
32. Arvidsson D, Svensson H, Haglund U: Laser-Doppler flowmetry for estimating liver blood flow. Am J Physiol 254: G471, 1988
33. Ramos E, Closa D, Hotter G, Rosello-Catafau J, Gelpi E, Fernandez-Cruz L: The impact of arterialization on prostanoid generation after liver transplantation in the rat. Transplantation 58: 140, 1994
34. Okano J, Shiota G, Kawasaki H: Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice. Hepatology 26: 1241, 1997
35. Clark BD, Bedrosian I, Schindler R, Cominelli F, Cannon JG, Shaw AR, Dinarello CA: Detection of interleukin 1α and β in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol 71: 2412, 1991
36. Warren JS, Yabroff KR, Remick DG, Kunkel SL, Chensue SW, Kunkel RG, Johnson KJ, Ward PA: Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 84: 1873, 1989
37. Karp GI, Marcum JA, Rosenberg RD: The role of tryptophan residues in heparin-antithrombin interactions. Arch Biochem Biophys 233: 712, 1984
38. Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Araki S, Takatsuki K: Homozygous variant of antithrombin III that lacks affinity for heparin: AT III Kumamoto. Thromb Haemost 61: 20, 1989
39. Okajima K, Abe H, Maeda S, Motomura M, Tsujihata M. Nagataki M, Okabe H, Takatsuki K: Antithrombin III Nagasaki (Serl 16-Pro): A heterozygous variant with defective heparin binding associated with thrombosis. Blood 81: 1300, 1993
40. Bajaj SP, Rapaport SI, Prodanos CA: A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 11: 397, 1981
41. Morita T, Jackson CM: Localization of the structural difference between bovine blood coagulation factor XI and XII to tyrosine 18 in the activation peptide. J Biol Chem 261: 4008, 1986
42. NeSheim ME, Kettner C, Shaw E, Mann KG: Cofactor depen-dence of factor Xa incorporation into the prothrombinase complex. J Biol Chem 256: 6537, 1981
43. Uchiba M, Okajima K, Abe H, Okabe H, Takatsuki K: Effect of nafamostat mesilate, a synthetic protease inhibitor, on tissue factor-factor VIIa complex. Thromb Res 74: 155, 1994
44. 1a in rats. Thromb Res 80: 201, 1995
45. Taylor FB Jr, Chang AK, Mather T, Blick K, Catlett R, Esmon CT: DEGR-factor Xa blocks disseminated intravascular coagulation initiated by E. coli without preventing shock or organ damage. Blood 78: 364, 1991
46. Colleti LM, Burtch GD, Remick DG, Strieter RM, Guice KS, Oldham KT, Campbell DA Jr: The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 49: 268, 1990
47. Shito M, Wakabayashi G, Ueda M, Shimazu M, Shirasugi N, Endo M, Mukai M, Kitajima M: Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 63: 143, 1997
48. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84: 1045, 1989
49. Baggiolini M, Clark-Lewis I: Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307: 97, 1992
50. Hisama N, Yamaguchi Y, Okajima K, Uchiba M, Murakami K, Mori K, Yamada S, Ogawa M: Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion of rat liver. Dig Dis Sci 41: 1481, 1996
51. Jochum M: Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation. Semin Hematol 32: 19, 1995 (suppl 2)